menu
    • menu

    Company profile for BiomX

    NEW Drugs in Dev: 10
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BiomX is a microbiome drug discovery company developing customized phage therapies that seek and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. We discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. The Company’s platforms use computational and synthetic biology and cutting-edge research.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiomXIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    7 Pinhas Sapir St. Floor 2, Ness Ziona 7414002
    Telephone
    Telephone
    +972 723942377
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biomx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biomxbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    34th NZW-Hamburg

    Not Confirmed

    envelop Contact Supplier

    34th NZW-Hamburg

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biomx Addresses Recent Stock Trading Activity Statement
    Biomx Addresses Recent Stock Trading Activity Statement

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226999/0/en/BiomX-Issues-Statement-Regarding-Recent-Common-Stock-Trading-Activity.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    BiomX Announces $3.0 Million Private Placement
    BiomX Announces $3.0 Million Private Placement

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210881/0/en/BiomX-Announces-3-0-Million-Private-Placement.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Biomx Halts Phase 2B BX004 Trial After Internal Review
    Biomx Halts Phase 2B BX004 Trial After Internal Review

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201429/0/en/BiomX-Announces-Discontinuation-of-Phase-2b-BX004-Trial-Following-Internal-Review.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Biomx Provides Update On BX004 Phase 2B Trial In Cystic Fibrosis
    Biomx Provides Update On BX004 Phase 2B Trial In Cystic Fibrosis

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194771/0/en/BiomX-Provides-Update-on-BX004-Phase-2b-Trial-in-Cystic-Fibrosis.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Biomx Announces 1-For-19 Reverse Stock Split
    Biomx Announces 1-For-19 Reverse Stock Split

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188632/0/en/BiomX-Inc-Announces-1-for-19-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    BiomX Updates Q3 2025 Financials & Programs
    BiomX Updates Q3 2025 Financials & Programs

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186128/0/en/BiomX-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Program-Updates.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search